AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

RADIOPHARM THERANOSTICS LTD

0.007

-0.001-12.50%

Volume:1.11M

Turnover:8K

Market Cap:30.36M

PE:-0.39

High:0.008

Open:0.008

Low:0.007

Close:0.008

52wk High:0.040

52wk Low:0.007

Shares:4.34B

Float Shares:3.34B

Volume Ratio:0.13

T/O Rate:0.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.018

EPS(LYR):-0.018

ROE:-174.71%

ROA:-44.61%

PB:1.23

PE(LYR):-0.39

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Radiopharm Says Interim Phase 2b Rad101 PET Trial Meets Primary Endpoint with 93% MRI Concordance

Press Release: Radiopharm Theranostics Selected for Late-Breaking Oral Presentation of Positive Data from Interim Analysis of U.S. Phase 2b Imaging Trial of Rad101 at 2026 Society of Neuro-Oncology Annual Meeting

Radiopharm Theranostics Holds General Meeting; All Resolutions Carried by Poll

Radiopharm Reports Positive Phase 1 Imaging Data for Rad301 in Pancreatic Cancer Patients

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/RAD.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"RAD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RAD.AU\",,,,,undefined,":{"symbol":"RAD.AU","market":"AU","secType":"STK","nameCN":"RADIOPHARM THERANOSTICS LTD","latestPrice":0.007,"timestamp":1789525924440,"preClose":0.008,"halted":0,"volume":1108462,"delay":0,"changeRate":-0.125,"nameEN":"RADIOPHARM THERANOSTICS LTD","floatShares":3342779849,"shares":4337549000,"eps":-0.0179,"marketStatus":"Trading","change":-0.001,"latestTime":"09-16 12:35:03 AEST","open":0.008,"high":0.008,"low":0.007,"amount":7815,"amplitude":0.125,"askPrice":0.008,"askSize":4916237,"bidPrice":0.007,"bidSize":6815403,"shortable":3,"etf":0,"ttmEps":-0.0179,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789538400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.008,"openAndCloseTimeList":[[1789516800000,1789538400000]],"volumeRatio":0.134626,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"RAD.AU","preClose":0.008,"auctionPrice":0.008,"auctionVolume":55666,"auctionTime":1789516742732,"referenceTime":1789468203091,"auction":1,"marketStatus":"盘前竞价","timestamp":1789516742732}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RAD.AU\",,,,,undefined,":{"symbol":"RAD.AU","floatShares":3342779849,"roa":"-44.61%","roe":"-174.71%","lyrEps":-0.0179,"volumeRatio":0.134626,"shares":4337549000,"dividePrice":0,"high":0.008,"amplitude":0.125,"preClose":0.008,"low":0.007,"week52Low":0.007,"pbRate":"1.23","psRate":"2.25","week52High":0.04,"institutionHeld":0,"latestPrice":0.007,"committee":0.161884,"eps":-0.0179,"divideRate":0,"volume":1108462,"delay":0,"ttmEps":-0.0179,"open":0.008,"prevYearClose":0.025,"prevWeekClose":0.008,"prevMonthClose":0.01,"prevQuarterClose":0.019,"fiveDayClose":0.009,"twentyDayClose":0.012,"sixtyDayClose":0.019,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RAD.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RAD.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RAD.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667572665","title":"Radiopharm Says Interim Phase 2b Rad101 PET Trial Meets Primary Endpoint with 93% MRI Concordance","url":"https://stock-news.laohu8.com/highlight/detail?id=2667572665","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667572665?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:05","pubTimestamp":1789387544,"startTime":"0","endTime":"0","summary":"Radiopharm says interim Phase 2b RAD101 PET trial meets primary endpoint with 93% MRI concordanceRadiopharm Theranostics flagged positive interim Phase 2b imaging data for RAD101 in suspected recurren","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL54ZDHc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BQXX3C00.GBP","LU2210149790.SGD","LU0314104364.USD","SG9999014013.SGD","LU2095319765.USD","IE00B3QW5Z07.USD","SG9999014039.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","SG9999014005.SGD","IE00BQXX3D17.EUR","LU2210150020.SGD","BK7067","BCDF","NDAQ","IE00BN0W2V16.EUR","RAD.AU","SG9999014021.USD","BK4112","IE00BKPKM429.USD","IE00BQXX3F31.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667037663","title":"Press Release: Radiopharm Theranostics Selected for Late-Breaking Oral Presentation of Positive Data from Interim Analysis of U.S. Phase 2b Imaging Trial of Rad101 at 2026 Society of Neuro-Oncology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2667037663","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667037663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:00","pubTimestamp":1789387200,"startTime":"0","endTime":"0","summary":"RAD101 PET demonstrated 93% concordance with MRI across all evaluable lesions, meeting the trial's primary endpointMeeting with FDA planned on October 1(st) to align on RAD101Phase 3 pivotal trial pro","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRS","RADX","BK7067","BK4139","RAD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666552177","title":"Radiopharm Theranostics Holds General Meeting; All Resolutions Carried by Poll","url":"https://stock-news.laohu8.com/highlight/detail?id=2666552177","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666552177?lang=en_us&edition=fundamental","pubTime":"2026-09-11 20:02","pubTimestamp":1789128139,"startTime":"0","endTime":"0","summary":"Radiopharm Theranostics holds general meeting; all resolutions carried by pollRadiopharm Theranostics held a general meeting on Friday.Shareholders ratified the prior issue of First Tranche Placement ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL9bVlB2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAD.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666551587","title":"Radiopharm Reports Positive Phase 1 Imaging Data for Rad301 in Pancreatic Cancer Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2666551587","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666551587?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:04","pubTimestamp":1788951890,"startTime":"0","endTime":"0","summary":"Radiopharm reports positive Phase 1 imaging data for RAD301 in pancreatic cancer patientsRadiopharm Theranostics reported positive Phase 1 imaging results for RAD301 in healthy volunteers, patients wi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL79Nw0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","IE00BQXX3F31.USD","BK4588","BK4112","BCDF","IE00B64PRP62.GBP","SG9999014013.SGD","LU2210150020.SGD","IE00BKPKM429.USD","LU2095319765.USD","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","IE00BN0W2T93.GBP","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014039.USD","BK7067","SG9999014005.SGD","RAD.AU","IE00BN0W2V16.EUR","NDAQ","IE00BQXX3D17.EUR","SG9999014021.USD","IE00B3QW5Z07.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":18,"pageCount":1,"totalSize":71,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RAD.AU\",params:#limit:6,delay:true,,,undefined,":[]}}